This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo

A Patent Sea Change: The First Serving of Major Global Patent Law Changes Begins

Abstract

This decade brings a sea change in patent law, with significant changes to the patent systems of Europe, the United States and Australia as well as a rapidly maturing Chinese patent system. The most significant of all the global changes may be occurring in Europe. Following at least a quarter century of debate, the European Council of Ministers reached an agreement for the “unification” of the European patent litigation system. The new system entirely changes the way we will be able to enforce patents in Europe and is equivalent in patent law impact to the creation of the single European currency. More debate will be necessary (as well as overcoming potential legal challenges to the basis of the agreement) to agree on the final form of the unified European court system, but the final treaty is expected to be signed in late 2012, and the system implemented in 2014.

Read Paper

Author

Jason Garbell
Senior Patent Counsel, Novozymes AS, Denmark

Senior Manger with Novozymes North America (Patent and Licensing Department). Employed with Novozymes since 2000, and recently returned to the US from an expat assignment in Novoymes' headquarters in Denmark. Prior to employment with Novozymes, was employed by an intellectual property law firm in New Jersey. Registered to practice in New York, New Jersey and before the US Patent & Trademark Office. Undergraduate degrees from University of Texas (Microbiology), and law degree from Case Western Reserve University.

Company

Novozymes AS

Novozymes A/S (Novozymes) is a Denmark-based biotech company and is headquartered in Bagsvaerd, Denmark. Novozymes is principally engaged in the industrial enzyme business. Novoyzmes develops, produces and distributes enzymes for many industries, including household care (detergents), fuel, food and feed industries. Novozymes also offers micro-organisms and microbial based products which are used in agriculture, industrial and municipal wastewater treatment, and household care. Novozymes also provides various biopharmaceutical ingredients for the pharmaceutical industry. Novozymes operates through its wholly owned subsidiaries, and has operations in Denmark, Canada, China, Japan North America, South America, Sweden and the United Kingdom.

Related Papers

Patent Strategies for Attenuated Pathogen Vaccines
Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more
Portrait image of David Dolberg
David Dolberg
Senior Director of Intellectual Property, Sanaria Inc., USA
Ways to Avoid Having your Patents Cellected*
The Court of Appeals for the Federal Circuit caused frustrations when it decided to affirm the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are...Read more
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Michelle E. O'Brien
Michelle E. O'Brien
Partner, Marbury Law Group, USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Section 112 Requirements for Life Sciences Patents
35 U.S.C. §112(a) of the US Patent Act is one of the integral parts of the quid pro quo patent system that balances the benefit of disclosure of the invention...Read more
Portrait image of Anagha Tendulkar
Anagha Tendulkar
In-house Patent Counsel, Cipla, India
A Current Look at the State of Inequitable Conduct and Other Equitable Concerns
Inequitable conduct is an “equitable defense to patent infringement that, if proved, bars enforcement of a patent. ” Therasense, Inc. v. Becton, Dickinson & Co. , 649 F. 3d 1276,...Read more
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Portrait image of Jordan Cowger
Jordan Cowger
Finnegan, USA
Portrait image of Melissa Santos
Melissa Santos
Finnegan, USA
Portrait image of Stacy Lewis
Stacy Lewis
Law Clerk, Finnegan, USA
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA